Analgesia Nociception Index for Pain Monitoring in Intensive Care Units

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-11

Study Completion Date

2022-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the usability of ANI in patients who will be treated in intensive care unit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nociception Level Index as Monitorization of Pain at the Intensive Care

NCT05762666

Intensive Care, Surgical Anesthesia, General

COMPLETED NA

Monitoring Analgesia by ANI (Analgesia The Nociception Index)

NCT03749304

Nociceptive Pain Surgical Procedure, Unspecified

COMPLETED NA

Nociception Monitoring in Intensive Care

NCT06270264

Unconscious State Pressure Ulcer

COMPLETED NA

Analgesia Nociception Index (ANI) in Intracranial Surgical Anesthesia

NCT06752824

Pain, Postoperative Analgesia Supratentorial Brain Tumor +4 more

COMPLETED

Effect of Perioperative Factors on the Analgesia Nociception Index

NCT02305576

Intraoperative Neurophysiological Monitoring

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to examine the usability of Analgesia Nociception Index in patients who will be treated in intensive care unit ( a- Cardiovascular b- surgical c- internal diseases), mechanically ventilated and lacking communication. The investigators will examine whether the positive inotropic/vasoconstrictor agents will have any effect on Analgesia Nociception Index.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Related Disorder Pain Intensive Care Unit Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intensive Care Patients (Cardiovascular)

Intensive care unit patients, mechanically ventilated and lacking communication. Will examine whether the positive inotropic/vasoconstrictor agents will have any effect on Analgesia Nociception Index.

Analgesia Nociception Index (ANI)

Intervention Type DEVICE

Monitorization of Analgesia Nociception Index in Intensive Care Patients

Intensive Care Patients (Internal diseases)

Intensive care unit patients, both mechanically ventilated and lacking communication and mechanically ventilated and conscious. Will examine whether the positive inotropic/vasoconstrictor agents will have any effect on Analgesia Nociception Index.

Analgesia Nociception Index (ANI)

Intervention Type DEVICE

Monitorization of Analgesia Nociception Index in Intensive Care Patients

Intensive Care Patients (Obese)

Intensive care unit patients. Will examine whether the positive inotropic/vasoconstrictor agents will have any effect on Analgesia Nociception Index.

Analgesia Nociception Index (ANI)

Intervention Type DEVICE

Monitorization of Analgesia Nociception Index in Intensive Care Patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analgesia Nociception Index (ANI)

Monitorization of Analgesia Nociception Index in Intensive Care Patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intensive Care Cardiovascular Patients Group 1 - Patients aged from 18 to 80 years, scheduled for elective isolated coronary bypass graft (CABG) for 2-4 vessel disease, without any perioperative complications, and who were postoperatively monitored via the analgesia nociception index in the cardiovascular intensive care will be included.
* Intensive Care Internal Diseases Group 2 - Patients aged from 18 to 80 years, intubated or tracheostomized, In mechanical ventilation with Pressure-Controlled Ventilation mode, under perfusion neuromuscular blocker, Normothermic, non-cooperative and/or sedated and neuromuscular blocker
* Intensive Care Patients (Obese) Group 3 - Post Bariatric surgery, over 40 BMI

Exclusion Criteria

* Intensive Care Cardiovascular Patients Group 1 Patients who required emergency surgery, had significant preoperative chronic pain, had autonomic nervous system anomalies and patients with rhythm will be excluded from the study.
* Intensive Care Internal Diseases Group 2 Ramsey sedation scale under 5, cooperative, with spontaneous breathing effort and extremity movement, non sinusal cardiac rhythm
* Intensive Care Patients (Obese) Group 3 - patients under 40 BMI

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No